[
    [
        {
            "time": "",
            "original_text": "白雲山(00874.HK)旗下收到阿咖酚散等22個藥品的註冊批件",
            "features": {
                "keywords": [
                    "白雲山",
                    "阿咖酚散",
                    "藥品",
                    "註冊批件"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫療",
                    "製藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山(00874.HK)旗下收到阿咖酚散等22個藥品的註冊批件",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "白雲山：22個藥品收到再註冊批件",
            "features": {
                "keywords": [
                    "白雲山",
                    "藥品",
                    "再註冊批件"
                ],
                "sentiment_score": 0.65,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫療",
                    "製藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山：22個藥品收到再註冊批件",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "白雲山(600332.SH)：收到阿咖酚散等22個藥品的藥品再註冊批件",
            "features": {
                "keywords": [
                    "白雲山",
                    "阿咖酚散",
                    "藥品",
                    "再註冊批件"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫療",
                    "製藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山(600332.SH)：收到阿咖酚散等22個藥品的藥品再註冊批件",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]